International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10010235
Original Article
Clinical Profile and Outcome of Patients Presenting with Severe Thrombocytopenia in A Tertiary Care Hospital
 ,
 ,
Published
Oct. 1, 2023
Abstract

BACKGROUND: Thrombocytopenia is a prevalent problem for physicians of many specialties in tropical areas such as India. In many etiological disorders, thrombocytopenia manifests as an asymptomatic condition that might progress to a life-threatening condition requiring blood transfusion. Malaria and dengue fever infections are generally linked with thrombocytopenia, with variable clinical patterns. The most prevalent cause of thrombocytopenia is infection. The aim of present study the clinical profile and outcome of patients presenting with severe thrombocytopenia.

METHODOLOGY: A prospective study was conducted in patients presented with severe thrombocytopenia in Dayanand Medical College and Hospital, Ludhiana from 1/03/2021 to 28/02/2022.The patients were followed up during their hospital stay and further followed up on OPD basis for 6 weeks or till the response was achieved..

RESULTS: Tropical fever was the most common cause of severe thrombocytopenia with 61 cases followed by sepsis with 23 cases. Bleeding manifestations were seen in 43.08% patients. Complete response was seen in 80% of the tropical fever, 43% of sepsis and 66% of ITP patients. Mortality was maximum in patients with sepsis induced thrombocytopenia.

CONCLUSION: Tropical fever is the commonest diagnosis made in patients who are detected to have severe thrombocytopenia. Treatment of the patients varied with the underlying etiology. Mortality was maximum in sepsis induced thrombocytopenia.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1488 Views
279 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved